ICI Cardiovascular Complications Guidance

• Cardiovascular risk assessment and baseline biomarkers

  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
  • IOCN and BCOS ' Baseline Cardiac Biomarker Consensus Statement' - due for release November 2024

• Myocarditis diagnosis

  Investigation and management

  • The Clatterbridge Cancer Centre Myocarditis Guideline
  • ESMO Management of toxicities from Immunotherapy

• ECG features and monitoring in suspected myocarditis

  • Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
  • Electrocardiographic features of immune checkpoint inhibitor associated myocarditis